| Trial ID: | L6114 |
| Source ID: | NCT00699322
|
| Associated Drug: |
Sitagliptin
|
| Title: |
Effect of Dipeptidyl Peptidase-IV Inhibitor and Sulfonylurea on Glucose Variability and Oxidative Stress
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: Sitagliptin|DRUG: Glimepiride
|
| Outcome Measures: |
Primary: Glucose variability, 1 month | Secondary: oxidative stress markers (oxidized LDL, N-carboxymethyl-lysine(CML), nitrotyrosine, 8-iso-prostaglandinF2α, 8-OhDG), 1 month
|
| Sponsor/Collaborators: |
Sponsor: The Catholic University of Korea | Collaborators: MSD Korea Ltd.
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
36
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2008-06
|
| Completion Date: |
2010-06
|
| Results First Posted: |
|
| Last Update Posted: |
2009-10-29
|
| Locations: |
Kangnam St. Mary's hospital, Seoul, 137-701, Korea, Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT00699322
|
